Barriers for small business to enter international market - from Taiwan experience
- At: 2011 FIP Congress in Hyderabad (India)
- Type: Poster
- By: CHEN, Yu-Yin (Twi Pharmaceuticals, Inc., Taipei, China Taiwan)
In Taiwan, managing a generic pharmaceutical product is relatively easier than a brand drug product for small business because of the huge investment of pre-clinical and clinical trial. However, according to US FDA and other health authorities' reports, there are less and less new chemical entity (NCE) drugs approved in each year, while more and.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.